Candidate gene polymorphisms and clinical implications of the use of psychostimulants in adults with mood or attentional deficit disorders: A systematic review

Candidate gene polymorphisms and clinical implications of the use of psychostimulants in adults with mood or attentional deficit disorders: A systematic review

Introduction: Psychostimulants are FDA-approved for treating attention deficit hyperactivity disorder (ADHD). They are often prescribed off-label for mood disorders (in the majority of cases for augmentation of major depressive disorder [MDD] or treatment-resistant cases) with particular concerns in...

Full description

Bibliographic Details
Main Authors: Nicolas A. Nuñez, Sofia Jezzini-Martinez, Ada Man-Choi Ho, Manuel Gardea-Resendez, Larry J. Prokop, Balwinder Singh, Paola Margarita Robledo-Atilano, Francisco Romo-Nava, Marin Veldic, Susan L. McElroy, Mark A. Frye, Alfredo B Cuellar-Barboza
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Biomarkers in Neuropsychiatry
Subjects:
Stimulants
Bipolar disorder
Major depression
Pharmacogenetics
ADHD
Systematic review
Online Access:http://www.sciencedirect.com/science/article/pii/S2666144624000108

Internet

http://www.sciencedirect.com/science/article/pii/S2666144624000108

Similar Items